Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
EV/EBITDA
92.68 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Progenics Pharmaceuticals Inc's enterprise value is $274.52 Mil. Progenics Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $2.96 Mil. Therefore, Progenics Pharmaceuticals Inc's EV/EBITDA ratio for today is 92.68.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Progenics Pharmaceuticals Inc's stock price is $5.50. Progenics Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2015 was $0.02. Therefore, Progenics Pharmaceuticals Inc's P/E Ratio for today is 366.67.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Progenics Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=274.517/2.962
=92.68

Progenics Pharmaceuticals Inc's current Enterprise Value is $274.52 Mil.
Progenics Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was -10.954 (Jun. 2014 ) + 36.878 (Sep. 2014 ) + -12.828 (Dec. 2014 ) + -10.134 (Mar. 2015 ) = $2.96 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Progenics Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=5.50/0.015
=366.67

Progenics Pharmaceuticals Inc's share price for today is $5.50.
Progenics Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2015 was -0.17 (Jun. 2014 ) + 0.51 (Sep. 2014 ) + -0.175 (Dec. 2014 ) + -0.15 (Mar. 2015 ) = $0.02.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Progenics Pharmaceuticals Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda -6.60-19.66-8.45-4.34-1.81-1.9817.68-2.34-6.15103.98

Progenics Pharmaceuticals Inc Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev2ebitda -2.34-6.76-5.47-6.89-6.15-4.62-5.4734.26103.98103.99
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK